Risk factors
Design Therapeutics (DSGN) risk factors
Item 1A of every Design Therapeutics, Inc. 10-K on file, and what changed from one year to the next.
- FY2025 10-K risk factors
92 risks, 8 new, 3 dropped, 18 reworded since the prior year. New trade tariff risks were added alongside expanded discussions on healthcare legislation like the OBBBA and the ACA.
Filed Mar 09, 2026 - FY2024 10-K risk factors
87 risks. Design Therapeutics faces heavy reliance on its novel GeneTAC platform, unproven clinical candidates like DT-216, and ongoing capital needs.
Filed Mar 10, 2025